Patents Assigned to University of Kent, School of Pharmacy
  • COMPOSITIONS AND METHODS RELATED TO LATROPHILINS AS BIOMARKERS FOR HAEMATOPOIETIC CELL CANCER
    Publication number: 20220042996
    Abstract: Disclosed is the use of latrophilin expression as a biomarker for the diagnosis of haematopoietic cell cancer in a subject, together with methods for diagnosis and a kit for the detection of latrophilin expression on white blood cells collected from a subject.
    Type: Application
    Filed: October 12, 2021
    Publication date: February 10, 2022
    Applicant: University of Kent, School of Pharmacy
    Inventors: Vadim Sumbayev, Yuri Ushkaryov, Bernhard Gibbs